.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
McKesson
AstraZeneca
Teva
Johnson and Johnson
Baxter
Citi
McKinsey
Fish and Richardson
Merck

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202845

« Back to Dashboard
NDA 202845 describes DIFLUNISAL, which is a drug marketed by Watson Labs, Idt Australia Ltd, Heritage Pharma, Zydus Pharms Usa Inc, Allied Pharma Inc, Teva, and Purepac Pharm, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the DIFLUNISAL profile page.

The generic ingredient in DIFLUNISAL is diflunisal. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diflunisal profile page.

Summary for NDA: 202845

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 202845

Suppliers and Packaging for NDA: 202845

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIFLUNISAL
diflunisal
TABLET;ORAL 202845 ANDA Rising Pharmaceuticals Inc. 64980-181 64980-181-01 100 TABLET, FILM COATED in 1 BOTTLE (64980-181-01)
DIFLUNISAL
diflunisal
TABLET;ORAL 202845 ANDA Rising Pharmaceuticals Inc. 64980-181 64980-181-05 500 TABLET, FILM COATED in 1 BOTTLE (64980-181-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Mar 8, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Accenture
Dow
Healthtrust
Teva
Queensland Health
Harvard Business School
McKinsey
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot